News

FDA Adopts Interim Plan to Avoid Shortage of Medically Necessary Opioid

0

The FDA has amended its March 30, 2009, action warning manufacturers to stop the production and distribution of certain unapproved prescription opioids so that one particular type of opioid will be available on an interim basis.

Benzyl Alcohol Lotion Approved for Head Lice

0

The FDA has approved a new prescription medication for treating head lice (Pediculosis capitis) infestation.

Flax in Diet Means Fewer Tumors

0

New research from South Dakota State University offers evidence that including flax in the diet may help prevent colorectal tumors or keep tumors from growing as quickly when they do form.

Link Between Osteoporosis Drugs and Heart Problems Probed

0

New research at Wake Forest University School of Medicine evaluated the link between a common class of drugs used to prevent bone fractures in osteoporosis patients and the development of irregular heartbeat.

Treatment for Acid Reflux Does Not Improve Asthma

0

New research suggests that a widely used treatment for persistent acid reflux among asthma patients doesn't actually improve their quality of life.

Soybean Component Reduces Menopause Effects

0

Soy aglycons of isoflavone (SAI), a group of soybean constituent chemicals, have been shown to promote health in a rat model of the menopause.

Attack of the Clones: Monoclonal Antibody Therapies for Cancer

5

For all the debate about cloning over the past several years, many people are still alive today thanks to the power of clones, specifically, monoclonal antibodies (MAbs).

Biology of Flushing Could Renew Niacin as Cholesterol Drug

0

Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.

Alternative Therapies Can Be Safe, Effective for Children

0

Today, more children than ever are being treated with complementary and alternative therapies.

FDA OKs Malaria Drug

0

The FDA has approved Coartem tablets (artemether and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least 5 kg (approximately 11 pounds).

Syndicate content